These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 343957)

  • 41. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.
    Moore AM; Prescott M; Marshall CJ; Yip SH; Campbell RE
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):596-601. PubMed ID: 25550522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The androgenic polycystic ovary.
    Greenblatt RB; Mahesh VB
    Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of the hyperandrogenism-polycystic ovary syndrome from isosexual precocious puberty: report of two cases.
    Root AW; Moshang T
    Am J Obstet Gynecol; 1984 Aug; 149(7):763-7. PubMed ID: 6465228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sex hormones and the skin].
    Boukhris R
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):831-42. PubMed ID: 2693519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth hormone insufficiency and its impact on ovarian function.
    Spiliotis BE
    Ann N Y Acad Sci; 2003 Nov; 997():77-84. PubMed ID: 14644812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gn-RH loading test].
    Aisaka K
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():54-7. PubMed ID: 16689284
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
    Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
    Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Polycystic ovary syndrome: a hypothalamic or a gonadal anomaly?].
    Ayala-Ruíz A; Valenzuela S
    Gac Med Mex; 1990; 126(2):108-13. PubMed ID: 2201581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J; Quigley MM
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls].
    Ságodi L; Barkai L
    Orv Hetil; 2013 Jan; 154(4):136-42. PubMed ID: 23335723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polycystic ovary syndrome.
    Venturoli S; Porcu E; Flamigni C
    Curr Opin Pediatr; 1994 Aug; 6(4):388-96. PubMed ID: 7951658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evolution of polycystic ovaries in a girl with hypogonadotropic hypogonadism before puberty and during puberty induced with pulsatile gonadotropin-releasing hormone.
    Stanhope R; Adams J; Pringle JP; Jacobs HS; Brook CG
    Fertil Steril; 1987 May; 47(5):872-5. PubMed ID: 3552755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperandrogenism and anovulation].
    Presl J
    Cesk Gynekol; 1979 Apr; 44(3):223-4. PubMed ID: 109216
    [No Abstract]   [Full Text] [Related]  

  • 58. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Obesity and polycystic ovary syndrome: reproductive issues].
    Dewailly D
    Bull Acad Natl Med; 2008 Apr; 192(4):649-59; discussion 659-60. PubMed ID: 19024937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome.
    Hall JE; Taylor AE; Martin KA; Crowley WF
    Ann N Y Acad Sci; 1993 May; 687():182-92. PubMed ID: 8323172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.